0.95 USD
↗ 0.05 (5.01%)AT CLOSE (11:59 AM EDT)
Bone Biologics Corp Common Stock
BBLGNASDAQ • USD
1.01
↗ 0.06 (6.66%)
POST MARKET (AS OF 07:47 PM EDT)
Post Market
AS OF 07:47 PM EDT
1.01
↗ 0.06 (6.66%)
Market: CLOSED
BBLG is currently priced at $0.94. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, BBLG appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 4, 2026.
Open?$0.92
High?$1.06
Low?$0.91
Prev. Close?$0.90
Volume?98.7K
Avg. Volume?48.4K
VWAP?$0.98
Rel. Volume?2.04x
Bid / Ask
Bid?$0.93 × 200
Ask?$1.02 × 100
Spread?$0.09
Midpoint?$0.98
Valuation & Ratios
Market Cap?1.7M
Shares Out?1.8M
Float?1.7M
Float %?92.2%
P/E Ratio?N/A
P/B Ratio?0.37
EPS?-$1.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
Employees
2
Market Cap
1.6M
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Website
Listed
2015-11-27
Address
2 BURLINGTON WOODS DRIVE,
BURLINGTON, MA 01803
Phone: (781) 552-4452
BURLINGTON, MA 01803
Phone: (781) 552-4452
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?-22.75Distress
Confidence?40%Low
Short InterestLow
Short % of Float?1.61%Low
Short Interest?26.6K
Days to Cover?1.0
Free Float1.7M
Avg Daily Volume70.9K
Settlement Date2026-07-15
Financial Health
Current Ratio?15.42Strong
Quick Ratio?15.42Strong
Cash Ratio?14.64Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.37CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.9CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-61.2%WEAK▾
S&P3
ROA?-57.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-2810179
Fundamentals ratios updated end of day